Argentina and Mexico to produce AstraZeneca Covid-19 vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Argentina and Mexico to produce AstraZeneca Covid-19 vaccine
Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America

Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America, Argentine President Alberto Fernandez said on Wednesday after a meeting with company executives involved in the project.

Argentina's President Alberto Fernandez gestures during the announcement that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential residence, in Buenos Aires, Argentina August 12, 2020.

An agreement signed between British pharmaceutical company AstraZeneca and the biotechnology company mAbxience of the INSUD Group includes transfer of technology to initially produce 150 million doses of the vaccine to supply all of Latin America with the exception of Brazil, the Argentine government said.

“Latin American production will be handled in Argentina and Mexico and that will allow timely and efficient access for all countries in the region,” Fernandez said.

Mexican Foreign Minister Marcelo Ebrard said later on Twitter that the deal had been pushed by Fernandez and Mexican President Andres Manuel Lopez Obrador. He said output of the vaccine could extend to 250 million doses.

AstraZeneca, Britain’s second-largest drugmaker, has long operations in Argentina. The company signed a deal with the foundation of Mexican billionaire Carlos Slim for the production of the vaccine, which is expected to be delivered in the first half of 2021, pending Phase III studies and regulatory approvals.

Mexico would provide more details on Thursday, said Ebrard, who thanked the Slim Foundation for financing production.

Arturo Elias, Slim’s spokesman, said a “very significant” sum was being invested in the scheme, without giving a figure.

“There’s a major economic commitment regardless of whether the vaccine works,” he told Reuters, noting that the foundation would start work immediately.

Fernandez said the deal “gives Argentina the peace of mind of being able to have the vaccine when required and at a reasonable price.”

Argentina, which has passed 5,000 coronavirus fatalities, posted a record daily number of COVID-19 infections on Wednesday with 7,663 new cases. Mexico has registered nearly 55,000 deaths and almost half a million cases.

Worldwide coronavirus cases have surpassed 20.4 million, according to the Johns Hopkins University. More than 12.7 million have recovered, and more than 745,000 have died. Back at home, India's coronavirus case tally has spiked by 66,999 cases in the last 24 hours. As per the latest data issued by the Ministry of Health and Family Welfare (MoHFW), India's COVID-19 case tally has surged to 23,96,638 out of which, 16,95,982 people have recovered while 6,53,622 are still suffering from the virus. COVID-19 death toll in India has gone past 47,000 with a single day jump of 942.ack at home, 

Story Courtesy: www.reuters.com 

Tags : #ArgentinaCovidNewsAug13 #AlbertoFernandez #MexicoCovidNewsAug13 #JohnHopkins #AstraZenecaNesAug13 #AstraZeneca #LatestPharmaNewsAug13 #LatestPharmaUpdateAug13 #mAbxience #InsudGroup

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026